An appropriate dose of peptide contained in the innovative form of the peptide analogue NL-BPC-157 is introduced into the body by swallowing an enteric capsule, made with patented peptide delivery technology, in the form of a double capsule, which reaches our digestive system without breaking down and migrates to the bloodstream, bringing the desired therapeutic effect
It is believed to fight the oxygen radicals and mutagenic properties that comes in our food intake and environment
The dual luciferase reporter assay was used to explore the direct binding between STAT6, HOXA2 and ATF6
Therapeutic Potential of Pro-angiogenic BPC157 Is Associated with VEGFR2 Activationand Up-Regulation
The effect of LA on the accumulation of fat in the liver is emphasized following different diet models (normal, high fat, high fructose, choline deficiency) and other models (gene mutation, diabetes), with the main mechanisms from mitochondrial function to inflammation and oxidative stress being summarized